U.S. Biotech Stock News

Expensify FY 2025 results set the stage for a margin story investors will be watching closely Expensify (EXFY) has laid out a challenging FY 2025 finish, with Q4 revenue of about US$35.2 million alongside a basic EPS loss of US$0.08 and net income excluding extra items showing a loss of US$7.1 million. Over recent periods the company has seen quarterly revenue move from US$37.0 million in Q4 FY 2024 to the US$35 million to US$36 million range across FY 2025. Basic EPS has stayed in loss...

Masimo’s FY 2025 Results Put Profitability Back in Focus Masimo (MASI) has wrapped up FY 2025 with fourth quarter revenue of US$412.5 million and basic EPS of US$1.19, while its trailing twelve month figures show revenue of US$1.5 billion and basic EPS of US$3.88. This gives investors a fresh read on how the business is converting sales into earnings. Over recent periods, the company has seen quarterly revenue move between US$343.3 million and US$600.7 million, with basic EPS ranging from a...

Walmart agreed to pay $100 million to settle an FTC and multi state lawsuit over alleged deceptive pay and tip practices for delivery drivers. The settlement requires Walmart to adopt systems that support accurate, transparent driver payments, with compliance monitoring over the next decade. Separately, Walmart is rolling out large scale AI training programs across its workforce to support its technology focused retail operations. For investors watching NasdaqGS:WMT, these developments sit...

Diversified Energy (NYSE:DEC) has just posted FY 2025 first half revenue of US$738.3 million, with Basic EPS of US$0.50 loss per share and net income loss excluding extra items of US$34.5 million, setting a cautious tone around profitability. The company has seen revenue move from US$348.7 million in the first half of 2024 to US$410.1 million in the second half of 2024 and then to US$738.3 million in the first half of 2025, while Basic EPS shifted from US$0.32 to US$2.11 loss and then to...

DENTSPLY SIRONA (XRAY) has wrapped up FY 2025 with fourth quarter revenue of US$961 million, alongside a basic EPS loss of US$0.73 and net income loss of US$146 million, while trailing twelve month figures show revenue of US$3.7 billion and a basic EPS loss of US$3.00 on a net income loss of US$598 million. Over the past six reported quarters, revenue has ranged from US$879 million to US$961 million and quarterly basic EPS has swung between a small profit of US$0.10 and losses of up to...

Fox Factory Holding (FOXF) has released its FY 2025 numbers with Q4 total revenue of US$361.1 million and a basic EPS loss of US$6.86, while trailing twelve month figures show revenue of US$1.5 billion and a basic EPS loss of US$13.03. The company’s total revenue increased from US$352.8 million in Q4 2024 to US$361.1 million in Q4 2025, while basic EPS moved from a small loss of US$0.00 to a much larger loss of US$6.86 over the same period, setting up a results season in which margins and the...

Public Service Enterprise Group (PEG) has wrapped up FY 2025 with fourth quarter revenue of US$2.9b and basic EPS of US$0.63, alongside trailing twelve month revenue of US$12.2b and EPS of US$4.22 that frame the latest print in a much broader earnings run. The company has seen quarterly revenue move from US$2.5b and EPS of US$0.57 in Q4 2024 to US$2.9b and EPS of US$0.63 in Q4 2025, while trailing twelve month EPS shifted from US$3.56 to US$4.22 over the same period. This sets up a results...

OneSpan FY 2025 results: margins front and center for investors OneSpan (OSPN) has closed out FY 2025 with Q4 revenue of US$62.9 million and basic EPS of US$1.15, supported by trailing twelve month revenue of US$243.2 million and EPS of US$1.91. The company has seen quarterly revenue range from US$56.2 million to US$63.4 million over the last six reported periods, while basic EPS has moved between US$0.17 and US$1.15. This gives investors a clear view of how earnings track alongside...

In February 2026, APA Corporation reported its fourth-quarter and full-year 2025 results, delivering US$1,978 million in quarterly revenue and US$279 million in net income, alongside average daily production of 459,767 BOE in the quarter and 454,716 BOE for the year. The company also exceeded earnings expectations, achieved a US$350 million cost-savings run rate ahead of schedule, and highlighted extensive Permian Basin drilling inventory and free cash flow strength as it confirmed a...

Pacira BioSciences (PCRX) just wrapped up FY 2025 with Q4 revenue of US$196.9 million and basic EPS of US$0.04, alongside trailing twelve month revenue of US$726.4 million and basic EPS of US$0.16. Over recent quarters, revenue has moved from US$168.9 million in Q1 2025 to US$196.9 million in Q4 2025, while quarterly EPS has ranged from a loss of US$0.11 in Q2 2025 to a profit of US$0.12 in Q3 2025 and US$0.04 in the latest quarter. This sets up a narrative that combines a return to...

Crinetics Pharmaceuticals (CRNX) closed out FY 2025 with Q4 revenue of US$6.2 million and a basic EPS loss of US$1.29, alongside a full year trailing basic EPS loss of US$4.95 on revenue of US$7.7 million. Over recent quarters the company has seen quarterly revenue move from US$0.14 million in Q3 2025 and US$1.03 million in Q2 2025 to US$6.2 million in Q4 2025, while quarterly basic EPS losses ranged between US$1.04 and US$1.38 per share across FY 2025. This provides context for investors as...

Betterware de México P.I. de (BWMX) has wrapped up FY 2025 with fourth quarter revenue of MX$3.8b and basic EPS of MX$6.71, alongside trailing 12 month EPS of MX$28.00 on revenue of MX$14.3b. This gives investors a clear view of both its latest quarter and its full year run rate. Over the past few quarters, revenue has ranged between MX$3.4b and MX$3.8b, while quarterly EPS has moved from MX$4.06 in Q1 2025 to MX$8.77 in Q2, MX$8.42 in Q3 and MX$6.71 in Q4, with trailing 12 month net income...

BioLife Solutions (BLFS) just closed out FY 2025 with Q4 revenue of US$24.8 million and basic EPS of US$0.04, alongside net income from continuing operations of US$2.1 million and earnings from discontinued operations of US$9.0 million. The company reported quarterly revenue moving from US$21.4 million in Q3 2024 to US$28.1 million in Q3 2025, while basic EPS was US$0.04 in both Q4 2024 and Q4 2025. This raises a key question for investors: how much of that top line is turning into...

PubMatic (PUBM) closed out FY 2025 with Q4 revenue of US$80.0 million and basic EPS of US$0.14, alongside trailing twelve month revenue of US$282.9 million and a basic EPS loss of US$0.31. Over recent quarters, the company has seen quarterly revenue move from US$63.8 million in Q1 2025 to US$80.0 million in Q4 2025, while basic EPS shifted from a loss of US$0.20 in Q1 to a profit of US$0.14 in Q4. For investors, the mix of improving quarterly EPS against a still loss making twelve month...

National HealthCare (NHC) has wrapped up FY 2025 with fourth quarter revenue of US$386.5 million and basic EPS of US$1.60, against a 12 month earnings growth figure of 17.7%. Over the past few periods, revenue has moved from US$369.4 million in Q4 2024 to US$373.7 million in Q1 2025, US$374.9 million in Q2 2025, US$382.7 million in Q3 2025 and now US$386.5 million in Q4 2025. Quarterly EPS has ranged from US$0.39 in Q4 2024 to US$2.78, US$2.09, US$1.53, US$2.53 and US$1.60 across the last...

Janux Therapeutics (JANX) closed out FY 2025 with Q4 revenue of US$0 and a basic EPS loss of US$0.51, keeping the focus squarely on how efficiently it is funding and progressing its pipeline rather than on top line growth. The company has seen quarterly revenue move between US$0 and US$10 million over the past year, while basic EPS losses have ranged from US$0.38 to US$0.55 per share. This sets up a story in which any potential upside depends heavily on whether management can convert this...

DoubleVerify Holdings (DV) closed out FY 2025 with fourth quarter revenue of US$205.6 million and basic EPS of US$0.18, while full year trailing twelve month figures show revenue of US$748.3 million and basic EPS of US$0.31. Over the past few quarters, revenue has moved from US$169.6 million in Q3 2024 to US$190.6 million in Q4 2024 and then to US$205.6 million in Q4 2025, with quarterly EPS shifting from US$0.11 to US$0.14 to US$0.18 over the same periods. This has created a results season...

SITE Centers (SITC) has just wrapped up FY 2025 with fourth quarter revenue of US$20.9 million and basic EPS of US$2.59, alongside net income excluding extra items of US$135.7 million and Funds From Operations of US$26.6 million. Over recent quarters the company has seen revenue move from US$42.7 million in Q1 2025 to US$33.4 million in Q2, US$26.6 million in Q3 and US$20.9 million in Q4, while quarterly basic EPS shifted from US$0.06 to US$0.88, then US$0.13, before landing at US$2.59 in the...

NetApp (NTAP) has put another solid quarter on the board, with Q3 2026 revenue of US$1.7 billion, basic EPS of US$1.69 and trailing twelve month EPS of US$6.08 helping frame how the latest print fits into its recent performance. The company has seen revenue move from US$1.66 billion in Q2 2025 to US$1.71 billion in Q3 2026, while quarterly basic EPS has ranged between US$1.16 and US$1.69 over that period. This sets up a story where a stable top line and consistent earnings keep margins firmly...

Compass Diversified (CODI) has just wrapped up FY 2025 with fourth quarter revenue of US$468.6 million and a basic EPS loss of US$0.95, while on a trailing twelve month basis revenue sits at about US$1.9 billion with a basic EPS loss of US$3.05. Over the past few quarters, the company has seen quarterly revenue move from US$426.7 million in Q2 2024 to US$456.6 million in Q3 2024 and then into the US$453.8 million to US$478.7 million range through 2025, alongside quarterly basic EPS losses...

Solventum (SOLV) has just wrapped up FY 2025 with Q4 revenue of US$1.998 billion, Basic EPS of US$0.36 and trailing twelve month EPS of US$8.94, alongside a very large one off gain that helped push earnings up 224.8% over the past year. Over the last few quarters the company has seen revenue move between US$2.070 billion and US$2.161 billion, while trailing twelve month net income excluding extra items has shifted from US$479 million in FY 2024 Q4 to US$1.56 billion in FY 2025 Q4. This leaves...

Clipper Realty FY 2025 results: revenue holds steady as losses persist Clipper Realty (CLPR) has posted its FY 2025 results with Q4 revenue of US$37.1 million and basic EPS of a US$0.28 loss, while trailing 12 month revenue stands at US$153.2 million and EPS at a US$1.38 loss. Over recent quarters the company has seen quarterly revenue move in a tight band between US$37.1 million and US$39.4 million, as net income swung from a Q1 loss of US$13.9 million to a Q4 loss of US$2.5 million and...

Recently, TransDigm Group outlined an aggressive acquisition program with three completed deals and nearly US$10.00 billion in remaining M&A capacity, while also lifting full-year guidance on the back of an improved revenue outlook and robust defense segment performance. A further development was Steve Cohen’s Point72 Asset Management initiating a new US$336.00 million position in TransDigm, taking ownership to about 0.45% of the company’s shares outstanding and underscoring heightened...

Aurinia Pharmaceuticals (AUPH) closed FY 2025 with Q4 revenue of US$77.1 million and basic EPS of US$1.60, alongside trailing twelve month EPS of US$2.14 on revenue of US$283.1 million. This frames a very strong headline earnings story. Over the past few quarters, the company has seen revenue move from US$59.9 million in Q4 2024 to US$77.1 million in Q4 2025, while quarterly EPS shifted from roughly breakeven at US$0.01 to US$1.60, with trailing twelve month net income reaching US$287.2...